Sales revenue of Saudi Chemical Holding Co.’s pharmaceutical segment dropped 5% year-on-year (YoY) to SAR 726 million in the first
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Most Read
Ubhar Capital issues Q2 2024 earnings estimates
Aramco says news on plan to bid for gas producer Santos ‘inaccurate’
Merrill Lynch says no price stabilization for Aramco shares so far
Saudi Aramco sets Arab Crude OSP for August
ACRSD imposes SAR 11.1M fine on capital market violators